GAG
ABBV icon

Goodman Advisory Group’s AbbVie ABBV Stock Holding History

Goodman Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-205
Closed -$44.6K – 70
2026
Q1 		$44.6K Hold
205
– – 0.01% 117
2025
Q4 		$46.8K Sell
205
-633
-76% -$144K 0.01% 103
2025
Q3 		$194K Sell
838
-488
-37% -$99.4K 0.05% 71
2025
Q2 		$246K Sell
1,326
-18,469
-93% -$3.43M 0.08% 51
2025
Q1 		$4.15M Buy
19,795
+2,295
+13% +$446K 1.26% 30
2024
Q4 		$3.11M Buy
17,500
+1,966
+13% +$361K 0.92% 34
2024
Q3 		$3.07M Buy
15,534
+1,620
+12% +$302K 0.88% 34
2024
Q2 		$2.39M Buy
13,914
+13,567
+3,910% +$2.25M 0.71% 34
2024
Q1 		$63.2K Hold
347
– – 0.02% 96
2023
Q4 		$53.8K Hold
347
– – 0.02% 91
2023
Q3 		$51.7K Sell
347
-134
-28% -$19.7K 0.02% 93
2023
Q2 		$64.8K Hold
481
– – 0.02% 80
2023
Q1 		$76.7K Buy
481
+134
+39% +$20.5K 0.04% 68
2022
Q4 		$56K Hold
347
– – 0.03% 71
2022
Q3 		$47K Hold
347
– – 0.03% 73
2022
Q2 		$53K Buy
+347
New +$53K 0.02% 75

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goodman Advisory Group's ABBV Position: Q2 2026 in Review

Goodman Advisory Group sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 205 shares — an estimated $44.6K sold.

Goodman Advisory Group first reported a position in ABBV in Q2 2022 and held it in 16 quarters. The position peaked at $4.15M in Q1 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Goodman Advisory Group reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • Goodman Advisory Group sold 205 AbbVie shares in Q2 2026, an estimated $44.6K.
  • Goodman Advisory Group first reported a position in AbbVie in Q2 2022 and held it in 16 quarters.
  • Goodman Advisory Group's AbbVie position peaked at $4.15M in Q1 2025.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Goodman Advisory Group's 13F filing for Q2 2026, filed 12 Aug 2026.